Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier

International Journal of Pharmaceutics

Volumn 438, Issue 1-2, 2012, Pages 11-19

  Hughey, Justin R ^a   Keen, Justin M ^a   Miller, Dave A ^b   Brough, Chris ^b   McGinity, James W ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b DisperSol Technologies LLC   (United States)

Author keywords

Hot melt extrusion; Hydroxypropyl methylcellulose; KinetiSol Dispersing; Polymer stability; Poorly water soluble

Indexed keywords

DRUG CARRIER; HYDROXYPROPYLCELLULOSE; ITRACONAZOLE; METHOXYLCELLULOSE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DEGRADATION; DISPERSION; DRUG FORMULATION; DRUG STABILITY; HIGH TEMPERATURE; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; THERMOSTABILITY; VISCOSITY;

DRUG CARRIERS; DRUG STABILITY; HOT TEMPERATURE; ITRACONAZOLE; METHYLCELLULOSE; SOLUBILITY; VISCOSITY;

EID: 84866478673     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.032     Document Type: Article

References (51)

1. A.J. Alvarez, A. Singh, and Myerson AS Polymorph screening: comparing a semi-automated approach with a high throughput method Cryst. Growth Des. 9 2009 4181 4188
2. R.J. Bastin, M.J. Bowker, and B.J. Slater Salt selection and optimisation procedures for pharmaceutical new chemical entities Org. Process Res. Dev. 4 2000 427 435
3. M.E. Brewster, R. Vandecruys, J. Peeters, P. Neeskens, G. Verreck, and T. Loftsson Comparative interaction of 2-hydroxypropyl-[beta]-cyclodextrin and sulfobutylether-[beta]-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions Eur. J. Pharm. Sci. 34 2008 94 103
4. C. Capone, L. Di Landro, F. Inzoli, M. Penco, and L. Sartore Thermal and mechanical degradation during polymer extrusion processing Polym. Eng. Sci. 47 2007 1813 1819
5. W.L. Chiou, and S. Riegelman Pharmaceutical applications of solid dispersion systems J. Pharm. Sci. 60 1971 1281 1302
6. K. Coppens, M. Hall, S. Mitchell, P. Nguyen, U. Shrestha, and P. Walia Thermal and rheological evaluation of pharmaceutical excipients for hot melt extrusion American Association of Pharmaceutical Scientists Annual Meeting and Exposition Baltimore, MD 2004
7. D.Q.M. Craig, and P.G. Royall The use of modulated temperature DSC for the study of pharmaceutical systems: potential uses and limitations Pharm. Res. 15 1998 1152 1153
8. D.Q.M. Craig, P.G. Royall, V.L. Kett, and M.L. Hopton The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems Int. J. Pharm. 179 1999 179 207
9. W. Curatolo, J.A. Nightingale, and S.M. Herbig Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu Pharm. Res. 26 2009
10. R.-M. Dannenfelser, H. He, Y. Joshi, S. Bateman, and A.T.M. Serajuddin Development of clinical dosage forms for a poorly water soluble drug. I: application of polyethylene glycol-polysorbate 80 solid dispersion carrier system J. Pharm. Sci. 93 2004 1165 1175
11. ® Dispersing Eur. J. Pharm. Biopharm. 74 2010 340 351
12. ® Dispersing for the production of plasticizer free amorphous solid dispersions Eur. J. Pharm. Sci. 40 2010 179 187
13. ® Dispersing: a comparative study to hot melt extrusion J. Pharm. Sci. 99 2010 1239 1253
14. ® Dispersing Drug Dev. Ind. Pharm. 36 2010 1064 1078
15. J.C. DiNunzio, D.A. Miller, W. Yang, J.W. McGinity, and R.O. Williams III Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole Mol. Pharm. 5 2008 968 980
16. D.T. Friesen, R. Shanker, M. Crew, D.T. Smithey, W.J. Curatolo, and J.A. Nightingale Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview Mol. Pharm. 5 2008 1003 1019
17. D.J. Goodwin, D.R. Picout, S.B. Ross-Murphy, S.J. Holland, L.G. Martini, and M.J. Lawrence Ultrasonic degradation for molecular weight reduction of pharmaceutical cellulose ethers Carbohydr. Polym. 83 2011 843 851
18. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
19. J. Haleblian, and W. McCrone Pharmaceutical applications of polymorphism J. Pharm. Sci. 58 1969 911 929
20. B.C. Hancock Amorphous pharmaceutical systems J. Swarbrick, Encyclopedia of Pharmaceutical Technology 2006 Informa Healthcare New York 83 91
21. B.C. Hancock, and M. Parks What is the true solubility advantage of the different forms? Pharm. Res. 17 2000 397 404
22. B.C. Hancock, S.L. Shamblin, and G. Zografi Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures Pharm. Res. 12 1995 799 806
23. ® Dispersing AAPS PharmSciTech 11 2010 760 774
24. ® Dispersing Int. J. Pharm. 419 2011 222 230
25. N. Jain, and S.H. Yalkowsky Estimation of the aqueous solubility. I: application to organic nonelectrolytes J. Pharm. Sci. 90 2001 234 252
26. N. Jain, G. Yang, S.G. Machatha, and S.H. Yalkowsky Estimation of the aqueous solubility of weak electrolytes Int. J. Pharm. 319 2006 169 171
27. B.K. Kang, J.S. Lee, S.K. Chon, S.Y. Jeong, S.H. Yuk, G. Khang, H.B. Lee, and S.H. Cho Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs Int. J. Pharm. 274 2004 65 73
28. C.M. Keary Characterization of METHOCEL cellulose ethers by aqueous SEC with multiple detectors Carbohydr. Polym. 45 2001 293 303
29. C.M. Keck, and R.H. Muller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16
30. C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60
31. X.-G. Li, M.-R. Huang, and H. Bai Thermal decomposition of cellulose ethers J. Appl. Polym. Sci. 73 1999 2927 2936
32. C.A. Lipinski Poor aqueous solubility - an industry wide problem in drug discovery Am. Pharm. Rev. 5 2002 82 85
33. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1996 1017 1025
34. C. Medina, D. Daurio, K. Nagapudi, and F. Alvarez-Nunez Manufacture of pharmaceutical co-crystals using twin screw extrusion: a solvent-less and scalable process J. Pharm. Sci. 99 2010 1693 1696
35. R. Mellaerts, C.A. Aerts, J.V. Humbeeck, P. Augustijns, G.V. den Mooter, and J.A. Martens Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials Chem. Commun. 2007 1375 1377
36. R. Mellaerts, J.A.G. Jammaer, M. Van Speybroeck, H. Chen, J.V. Humbeeck, P. Augustijns, G. Van den Mooter, and J.A. Martens Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen Langmuir 24 2008 8651 8659
37. R. Mellaerts, R. Mols, J.A.G. Jammaer, C.A. Aerts, P. Annaert, J. Van Humbeeck, G. Van den Mooter, P. Augustijns, and J.A. Martens Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica Eur. J. Pharm. Biopharm. 69 2008 223 230
38. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120
39. D.A. Miller, J.C. DiNunzio, W. Yang, J.W. McGinity, and R.O. Williams III Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition Drug Dev. Ind. Pharm. 34 2008 890 902
40. D.A. Miller, J.C. DiNunzio, W. Yang, J.W. McGinity, and R.O. Williams III Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption Pharm. Res. 25 2008 1450 1459
41. D.L. Pole Physical and biological considerations for the use of nonaqueous solvents in oral bioavailability enhancement J. Pharm. Sci. 97 2008 1071 1088
42. C.J. Porter, K.M. Wasan, and P. Constantinides Lipid-based systems for the enhanced delivery of poorly water soluble drugs Adv. Drug Deliv. Rev. 60 2008 615 616
43. C.W. Pouton Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S93 S98
44. M. Pudipeddi, and A.T.M. Serajuddin Trends in solubility of polymorphs J. Pharm. Sci. 94 2005 929 939
45. S.L. Raghavan, A. Trividic, A.F. Davis, and J. Hadgraft Crystallization of hydrocortisone acetate: influence of polymers Int. J. Pharm. 212 2001 213 221
46. A.T.M. Serajuddin Salt formation to improve drug solubility Adv. Drug Deliv. Rev. 59 2007 603 616
47. N.H. Shah, M.T. Carvajal, C.I. Patel, M.H. Infeld, and A.W. Malick Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharm. 106 1994 15 23
48. K. Six, H. Berghmans, C. Leuner, J. Dressman, K.V. Werde, J. Mullens, J. Benoist, M. Thimon, L. Meublat, G. Verreck, J. Peeters, M.E. Brewster, and Mooter GVd Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion. Part II Pharm. Res. 20 2003 1054 1057
49. V.J. Stella, and K.W. Nti-Addae Prodrug strategies to overcome poor water solubility Adv. Drug Deliv. Rev. 59 2007 677 694
50. P. Vishweshwar, J.A. McMahon, J.A. Bis, and M.J. Zaworotko Pharmaceutical co-crystals J. Pharm. Sci. 95 2006 499 516
51. C.M. Zaccaron, R.V.B. Oliveira, M. Guiotoku, A.T.N. Pires, and V. Soldi Blends of hydroxypropyl methylcellulose and poly(1-vinylpyrrolidone-co-vinyl acetate): miscibility and thermal stability Polym. Degrad. Stab. 90 2005 21 27